Published 5 hours ago • loading... • Updated 5 hours agoShow Less IconFate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of ... Summary by Hastings TribuneFT819 off-the-shelf CAR T-cell therapy product candidate continues to broaden patient access with 21 SLE patients now treated, including as outpatient administration in community hospitalsShare menu1 Articles1 ArticlesAllLeftCenter1RightSearch IconSort IconHastings TribuneCenterFactualityOwnershipFate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of ...FT819 off-the-shelf CAR T-cell therapy product candidate continues to broaden patient access with 21 SLE patients now treated, including as outpatient administration in community hospitals5 hours ago·Nebraska, United StatesRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources1Leaning Left0Leaning Right0Center1Last Updated5 hours agoBias Distribution100% CenterBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources are Center100% CenterC 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageHastings Tribune broke the news in Nebraska, United States 5 hours ago on Thursday, June 4, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsHastings, Nebraska Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsHastings, Nebraska Plus IconShow All